Veradermics, Inc Mentioned by Other
Announcements and disclosures made by other companies that explicitly identify this company. Each entry names the announcing company, publication date and relationship described. Includes supply, licensing, customer, property and other business relationships when disclosed. Company filings are labelled separately from newsroom announcements. Announced agreements do not prove a payment was made; absent amounts remain missing. All retained historical announcements remain available.
| Announced | Announcing company | Publication type | Relationship | What they announced | Disclosed amount | Term | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|
| Indivior Pharmaceuticals, Inc. (INDV) | | $4.250B | 14.09 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|